middl
east
respiratori
syndrom
mer
coronaviru
cov
emerg
recent
zoonot
sourc
caus
sever
pneumonia
patient
middl
east
travel
region
case
death
case
fatal
rate
report
http
wwwwhointemergenciesmerscoven
larg
fraction
merscov
transmiss
occur
health
care
set
approxim
case
consid
primari
gener
accept
dromedari
camel
larg
seroposit
merscov
throughout
arabian
peninsula
immedi
sourc
primari
human
infect
howev
major
mer
patient
report
camel
contact
make
sourc
infect
uncertain
one
possibl
intermediari
human
infect
camel
worker
cw
sinc
popul
extens
prolong
contact
anim
mer
detect
human
yet
viru
circul
camel
least
sinc
assess
serolog
test
spread
human
may
reflect
recent
intensif
camel
herd
arabian
peninsula
result
increas
camelhuman
interact
enhanc
human
infect
confound
epidemiolog
studi
merscovspecif
antibodi
respons
identifi
mani
infect
patient
transient
detect
patient
especi
mild
asymptomat
infect
thu
epidemiolog
studi
reli
serolog
test
predict
underestim
preval
human
infect
contrast
virusspecif
cell
respons
may
longer
last
thu
provid
accur
inform
preval
patient
recov
sever
acut
respiratori
syndrom
sar
virusspecif
cell
respons
could
detect
long
year
infect
antibodi
respons
detect
year
infect
addit
previou
studi
report
first
analysi
merscovspecif
cell
respons
mer
survivor
show
cell
respons
could
detect
patient
undetect
antibodi
respons
especi
mild
subclin
diseas
studi
address
possibl
role
cw
merscov
transmiss
analyz
virusspecif
antibodi
cell
respons
cw
welldocu
extens
exposur
nasal
oral
secret
herd
captur
transport
camel
kingdom
saudi
arabia
ksa
unlik
prior
report
found
high
percentag
cw
previous
infect
viru
although
clinic
diseas
consist
mer
result
indic
addit
studi
analyz
merscov
transmiss
cw
noncw
contact
warrant
data
also
provid
support
import
measur
cell
well
antibodi
respons
assess
preval
mer
potenti
infecti
diseas
obtain
peripher
blood
mononuclear
cell
pbmc
sera
cw
work
riyadh
new
camel
market
fig
healthi
control
ksa
iowa
usa
patient
demograph
clinic
inform
shown
tabl
detail
tabl
studi
particip
adult
male
cw
expos
camel
oral
nasal
secret
urin
cw
use
bare
hand
control
camel
transport
turn
neck
one
side
bodi
insert
hand
insid
camel
mouth
none
use
glove
mask
wash
hand
camel
contact
tabl
tabl
minor
histori
fever
cold
necessit
visit
emerg
room
within
previou
month
subject
expatri
worker
saudi
arabian
citizen
age
occup
underli
medic
condit
histori
tobacco
use
smoke
chew
consumpt
camel
product
milk
meat
also
shown
tabl
measur
merscovspecif
antibodi
ab
titer
sera
cw
healthi
donor
use
enzymelink
immunosorb
assay
elisa
immunofluoresc
assay
ifa
plaqu
reductionneutr
titer
assay
tabl
total
cw
sera
titer
greater
therefor
consid
posit
posit
sera
posit
borderlin
elisa
ifa
titer
respect
addit
cw
serum
posit
elisa
borderlin
ifa
tabl
notabl
merscovspecif
ab
level
compar
level
observ
survivor
mild
subclin
diseas
lower
sever
diseas
none
healthi
donor
ksa
serolog
evid
infect
assess
elisa
collect
result
indic
least
cw
serolog
evid
prior
merscov
infect
consid
antibodi
respons
may
transient
merscovinfect
patient
mild
asymptomat
diseas
next
measur
virusspecif
cell
respons
identifi
addit
infect
cw
first
determin
cellular
composit
pbmc
tabl
use
previous
describ
gate
strategi
see
also
fig
next
cell
respons
assess
use
pool
overlap
peptid
cover
structur
protein
n
encompass
n
ctermin
portion
spike
glycoprotein
nucleocapsid
n
protein
transmembran
envelop
e
protein
respect
assay
peptid
use
instead
virusinfect
cell
merscov
shown
induc
apoptosi
activ
cell
includ
virusspecif
one
infect
vitro
use
peptid
seri
intracellular
cytokin
tumor
necrosi
factor
tnf
stain
assay
pbmc
cw
healthi
donor
ksa
usa
fig
cell
respons
rel
low
sampl
count
posit
dualli
express
tnf
peptid
stimul
maxim
specif
cell
healthi
donor
respond
merscov
peptid
pool
pbmc
cw
contain
cell
respond
least
one
peptid
pool
cw
six
seroposit
consid
virusspecif
cell
respons
indetermin
addit
cw
describ
materi
method
taken
togeth
data
indic
seroneg
cw
contain
merscovspecif
cell
rate
merscov
infect
cw
greater
reveal
serolog
test
alon
merscovspecif
cell
cw
phenotyp
mixtur
effector
memori
effector
cell
fig
similar
result
obtain
analys
mer
survivor
howev
merscovspecif
cell
cw
phenotyp
effector
memori
cell
describ
mer
survivor
cell
cw
suggest
temra
effector
memori
cell
express
subset
cw
expos
camel
oral
nasal
secret
exposur
probabl
sourc
merscov
infect
next
attempt
determin
whether
age
smoke
handwash
camel
contact
consum
camel
meat
milk
specif
occup
camel
truck
driver
handler
herder
recent
histori
fever
cold
show
sign
relationship
infect
statu
howev
unabl
identifi
signific
correl
factor
merscov
infect
tabl
furthermor
group
cw
live
togeth
howev
found
evid
infect
individu
preferenti
domicil
togeth
although
dromedari
camel
consid
sourc
primari
nonnosocomi
human
mer
major
mer
case
describ
camel
exposur
make
critic
determin
precis
pathway
camel
human
transmiss
due
close
contact
camel
extens
exposur
camel
mouth
nasal
secret
urin
cw
high
risk
merscov
infect
could
serv
conduit
infect
gener
popul
result
previou
studi
examin
issu
mix
describ
increas
merscov
seroposit
camel
abattoir
worker
one
studi
show
camel
shepherd
abattoir
worker
preferenti
infect
merscov
compar
gener
popul
respect
serolog
evid
infect
use
cohort
cw
show
approxim
seroposit
merscov
addit
document
virusspecif
cell
respons
seroneg
cw
summari
total
cw
identifi
previous
merscov
infect
antibodi
cell
respons
measur
rate
merscov
infect
substanti
higher
report
previous
rais
question
whether
detect
nonspecif
respons
particularli
crossreact
one
common
human
respiratori
coronavirus
result
demonstr
merscovspecif
cell
respons
healthi
control
consist
other
show
low
level
merscov
seroposit
gener
ksa
popul
furthermor
crossneutr
human
coronavirus
hcov
report
previous
except
one
studi
demonstr
low
level
antimerscov
neutral
antibodi
sever
acut
respiratori
syndrom
sar
survivor
sarscov
longer
circul
human
popul
prior
infect
viru
unlik
sourc
mer
immunoposit
addit
consid
neutral
titer
greater
posit
diminish
issu
nonspecif
unexpect
result
detect
merscovspecif
cell
fig
b
previou
studi
virusspecif
cell
consist
effector
memori
phenotyp
cell
detect
context
human
infect
caus
dengu
viru
human
cytomegaloviru
hiv
enrich
cytotox
lymphocyt
ctl
associ
better
outcom
presenc
cell
may
contribut
milder
diseas
cw
conclus
reach
previou
studi
merscov
infect
cw
base
serolog
test
initi
screen
use
commerci
avail
elisa
confirm
ifa
neutral
assay
present
studi
also
obtain
low
seroposit
rate
base
elisa
posit
borderlin
pbmc
sampl
posit
elisa
analyz
rate
posit
would
littl
higher
valu
obtain
preval
studi
describ
hand
ifa
posit
borderlin
assay
posit
detect
greater
number
infect
cw
one
elisaposit
serum
neg
assay
togeth
result
suggest
high
rate
merscov
infect
report
result
select
camel
marketbas
cw
welldocu
exposur
camel
nasal
oral
secret
measur
virusspecif
cell
respons
cw
camel
market
facilit
herd
mix
larg
number
anim
small
enclosur
probabl
facilit
increas
viru
transmiss
merscovna
camel
camel
worker
scenario
similar
one
occur
sar
epidem
liveanim
market
enhanc
interspeci
spread
data
also
support
notion
use
multiprong
approach
measur
antibodi
titer
combin
assay
virusspecif
cell
respons
use
identifi
subject
mild
asymptomat
mer
therebi
better
determin
incid
preval
infect
inclus
cell
assay
identifi
addit
cw
merscov
infect
compar
identifi
serolog
test
alon
recogn
present
assess
cell
respons
technic
challeng
especi
countri
blood
collect
elev
ambient
temperatur
occur
camel
habitat
laboratori
resourc
limit
thu
improv
virusspecif
cell
assay
merscovspecif
elisa
requir
obtain
complet
pictur
true
preval
mer
first
year
mer
epidem
vast
major
case
result
nosocomi
transmiss
primari
mer
case
compris
major
fraction
new
case
merscov
transmit
camel
patient
without
evid
camel
contact
well
understood
result
indic
high
proport
cw
infect
combin
data
demonstr
patient
subclin
mer
contagi
suggest
plausibl
mechan
patient
without
document
camel
exposur
becom
infect
possibl
healthi
contact
cw
subclin
infect
expos
individu
underli
comorbid
otherwis
suscept
develop
clinic
diseas
result
need
confirm
larger
number
cw
preval
studi
longitudin
studi
order
identifi
addit
factor
contribut
transmiss
determin
whether
cw
repeatedli
infect
also
camel
infect
alphacoronavirus
betacoronavirus
includ
one
relat
import
determin
whether
virus
infect
human
especi
cw
unlik
whether
virus
induc
cell
respons
crossreact
merscovspecif
cell
final
paramount
directli
demonstr
infect
cw
contact
valid
notion
cw
sourc
spread
within
commun
determin
whether
cw
contagi
repeat
exposur
viru
cohort
studi
consist
cw
riyadh
new
camel
market
healthi
control
recruit
riyadh
ksa
iowa
usa
cw
select
randomli
goal
includ
camel
herder
handler
truck
driver
camel
herder
feed
water
medic
milk
camel
camel
handler
restrain
tighten
bind
camel
rope
prevent
ambul
transport
camel
short
intens
interact
camel
driver
help
handler
herder
load
camel
truck
cw
control
camel
place
bare
hand
mouth
camel
avoid
bitten
control
sampl
pbmc
obtain
anonym
donor
univers
iowa
health
care
worker
ksa
histori
mer
exposur
institut
review
board
king
faisal
specialist
hospit
research
center
jeddah
kfshrcj
ksa
approv
studi
written
inform
consent
obtain
studi
particip
cw
demograph
clinic
data
obtain
one
correspond
author
n
alagaili
time
blood
collect
use
written
questionnair
strain
merscov
passag
design
merscov
provid
bart
haagman
ron
fouchier
erasmu
medic
center
work
infecti
merscov
conduct
univers
iowa
biosafeti
level
laboratori
blood
collect
cw
riyadh
new
camel
market
fig
ambient
temperatur
high
transport
king
abdullah
intern
medic
research
center
riyadh
temperatur
maintain
approxim
collect
transport
pbmc
sera
prepar
whole
blood
serum
antimerscov
antibodi
titer
quantifi
elisa
immunofluoresc
assay
plaqu
reductionneutr
titer
assay
elisa
ifa
perform
describ
previous
use
commerci
avail
kit
euroimmun
medizinisch
labordiagnotika
ag
elisa
merscov
sspecif
antibodi
read
posit
neg
borderlin
plaqu
reductionneutr
titer
assay
serum
sampl
serial
dilut
dulbecco
modifi
eagl
medium
dmem
mix
equal
volum
merscov
contain
pfu
follow
incub
h
aliquot
ad
cultur
vero
cell
plate
incub
h
viru
titer
determin
previous
describ
assay
repeat
least
two
time
serum
sampl
ident
result
consid
sera
posit
greater
follow
antihuman
monoclon
antibodi
use
bd
horizon
biolegend
apc
efluor
invitrogen
biolegend
biolegend
biolegend
fitctcr
bd
ebiosci
biolegend
petnf
invitrogen
biolegend
fc
receptorblock
solut
obtain
biolegend
pbmc
prepar
blood
use
lympholyteh
cedarlan
per
manufactur
instruct
cell
store
liquid
nitrogen
prior
ship
univers
iowa
cell
analyz
surfac
stain
cell
block
fc
receptorblock
solut
label
livedead
stain
dye
thermo
fisher
stain
indic
antibodi
vitro
intracellular
cytokin
stain
cellswel
cultur
dish
h
presenc
peptid
gl
biochem
shanghai
brefeldin
bfa
bd
bioscienc
cell
label
cell
surfac
marker
fixedpermeabil
cytofixcytoperm
solut
bd
bioscienc
label
anticytokin
antibodi
flow
cytometri
data
acquir
bd
facsvers
flow
cytomet
analyz
use
flowjo
softwar
tree
star
inc
pbmc
consid
merscov
experienc
express
tnf
respons
peptid
stimul
stringent
approach
use
two
reason
first
fraction
cell
express
cytokin
lower
observ
previou
studi
mer
survivor
case
singlecytokineexpress
cell
level
similar
presenc
absenc
stimul
peptid
pool
eg
fig
c
measur
doubl
express
avoid
problem
second
cell
viabil
less
like
reflect
exposur
high
ambient
temperatur
time
blood
draw
reason
unabl
definit
determin
whether
cw
posit
neg
merscovspecif
cell
respons
classifi
indetermin
fisher
exact
test
use
compar
differ
group
p
valu
consid
statist
signific
